| Paul Bagnulo, MD | |
|
7315 212th St Sw, Suite 101, Edmonds, WA 98026-7610 | |
| (425) 775-9474 | |
| Not Available |
| Full Name | Paul Bagnulo |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 7315 212th St Sw, Edmonds, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174615421 | NPI | - | NPPES |
| 1069400 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 00013875 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Paul Bagnulo, MD 7315 212th St Sw, Suite 101, Edmonds, WA 98026-7610 Ph: (425) 775-9474 | Paul Bagnulo, MD 7315 212th St Sw, Suite 101, Edmonds, WA 98026-7610 Ph: (425) 775-9474 |
News Archive
The cause of a rare type of ovarian cancer that most often strikes girls and young women has been uncovered by an international research team led by the Translational Genomics Research Institute, according to a study published online today by the renowned scientific journal, Nature Genetics.
A new study shows that a drug, called daclizumab, is effective at reducing organ rejection and risk of infection in heart transplant patients. The multi-center study by cardiologists from the United States, Sweden, Germany and Canada will be published in the June 30 issue of The New England Journal of Medicine.
Nuvo Research Inc., a specialty pharmaceutical company focused on the research and development of drug products that are delivered into and through the skin using its topical and transdermal drug delivery technologies, and on the development of its immune modulating drug candidate WF10, today announced it will be meeting with several U.S. investment bankers, analysts and fund managers during J.P. Morgan's 29th annual Healthcare Conference held from January 10th to January 13th, 2011, in San Francisco, California.
As scientists learn more about which genetic mutations are driving different types of cancer, they're targeting treatments to small numbers of patients with the potential for big payoffs in improved outcomes.
› Verified 9 days ago
Clifford John Johnson, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 7320 179th St Sw, Edmonds, WA 98026 Phone: 425-743-5160 Fax: 425-743-5160 | |
Joe M Skariah, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 21911 76th Ave W, #110, Edmonds, WA 98026 Phone: 425-640-4950 Fax: 425-640-4958 | |
Louis P. Gianutsos, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 7315 212th St Sw Ste 101, Edmonds, WA 98026 Phone: 425-775-9474 Fax: 425-670-3554 | |
Steven Koh, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 21600 Highway 99 Ste 280, Edmonds, WA 98026 Phone: 360-901-6355 | |
Michelle R Richards, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 23320 Highway 99, Edmonds, WA 98026 Phone: 425-640-5500 | |
Dr. Emmy Nakasu Davison, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 21911 76th Ave W, Suite 110, Edmonds, WA 98026 Phone: 425-640-4950 Fax: 425-640-4958 | |
Monica Kimberly Park, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 7315 212th St Sw Ste 101, Edmonds, WA 98026 Phone: 425-775-9474 Fax: 425-670-3554 |